Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIVE-IIN-LATE: Stenting vs Medical Therapy in Idiopathic Intracranial Hypertension
NCT06945848Recruiting
- Sponsor
- CHU Montpellier
- Start
- Jan 2026
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
Randomised, open-label trial in idiopathic intracranial hypertension (IIH) (2 arms), sponsored by CHU Montpellier. Primary endpoint: Rate of patients with normalization of intra-cranial pressure at 3 months. Started Jan 2026; status: recruiting.
02
Conditions
idiopathic intracranial hypertension (IIH)
Beyond the preview
Go deeper on NCT06945848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06945848.